File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Five-year cost-effectiveness of Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care

TitleFive-year cost-effectiveness of Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care
Authors
Issue Date2017
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/DOM
Citation
Diabetes, Obesity and Metabolism, 2017, v. 19 n. 9, p. 1312–1316 How to Cite?
AbstractThis study evaluated the short-term cost-effectiveness of the Patient Empowerment Programme (PEP) for diabetes mellitus in Hong Kong. Propensity score matching was used to select a matched group of PEP and non-PEP subjects. A societal perspective was adopted to estimate the cost of PEP. The outcome measures were the cumulative incidence of all-cause mortality and diabetic complication over a five-year follow-up and the number needed to treat (NNT) to avoid one event. The incremental cost-effectiveness ratio (ICER) of cost per event avoided was calculated using the PEP cost per subject multiplied by the NNT. The PEP cost per subject from the societal perspective was US$247. There was a significantly lower cumulative incidence of all-cause mortality (2.9% vs 4.6%, p < 0.001), any diabetic complication (9.5% vs 10.8%, p = 0.001) and CVD events (6.8% vs 7.6%, p = 0.018), in the PEP group. The costs per death from any cause, DM complication or case of CVD avoided were US$14,465, US$19,617 and US$30,796, respectively. The extra amount allocated to running PEP was small and it appears cost-effective in the short-term as an addition to RAMP.
Persistent Identifierhttp://hdl.handle.net/10722/239500
ISSN
2019 Impact Factor: 5.9
2015 SCImago Journal Rankings: 2.729
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLian, JX-
dc.contributor.authorMcGhee, SM-
dc.contributor.authorSo, JC-
dc.contributor.authorChau, J-
dc.contributor.authorWong, CKH-
dc.contributor.authorWong, WCW-
dc.contributor.authorLam, CLK-
dc.date.accessioned2017-03-21T09:14:59Z-
dc.date.available2017-03-21T09:14:59Z-
dc.date.issued2017-
dc.identifier.citationDiabetes, Obesity and Metabolism, 2017, v. 19 n. 9, p. 1312–1316-
dc.identifier.issn1462-8902-
dc.identifier.urihttp://hdl.handle.net/10722/239500-
dc.description.abstractThis study evaluated the short-term cost-effectiveness of the Patient Empowerment Programme (PEP) for diabetes mellitus in Hong Kong. Propensity score matching was used to select a matched group of PEP and non-PEP subjects. A societal perspective was adopted to estimate the cost of PEP. The outcome measures were the cumulative incidence of all-cause mortality and diabetic complication over a five-year follow-up and the number needed to treat (NNT) to avoid one event. The incremental cost-effectiveness ratio (ICER) of cost per event avoided was calculated using the PEP cost per subject multiplied by the NNT. The PEP cost per subject from the societal perspective was US$247. There was a significantly lower cumulative incidence of all-cause mortality (2.9% vs 4.6%, p < 0.001), any diabetic complication (9.5% vs 10.8%, p = 0.001) and CVD events (6.8% vs 7.6%, p = 0.018), in the PEP group. The costs per death from any cause, DM complication or case of CVD avoided were US$14,465, US$19,617 and US$30,796, respectively. The extra amount allocated to running PEP was small and it appears cost-effective in the short-term as an addition to RAMP.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/DOM-
dc.relation.ispartofDiabetes, Obesity and Metabolism-
dc.rightsThis is the accepted version of the following article: Diabetes, Obesity and Metabolism, 2017, v. 19 n. 9, p. 1312–1316, which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1111/dom.12919/abstract-
dc.titleFive-year cost-effectiveness of Patient Empowerment Programme (PEP) for type 2 diabetes mellitus in primary care-
dc.typeArticle-
dc.identifier.emailLian, JX: tinalian@hku.hk-
dc.identifier.emailMcGhee, SM: smmcghee@hkucc.hku.hk-
dc.identifier.emailSo, JC: jcso@hku.hk-
dc.identifier.emailChau, J: jchau@hkucc.hku.hk-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailWong, WCW: wongwcw@hku.hk-
dc.identifier.emailLam, CLK: clklam@hku.hk-
dc.identifier.authorityMcGhee, SM=rp00393-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityWong, WCW=rp01457-
dc.identifier.authorityLam, CLK=rp00350-
dc.description.naturepostprint-
dc.identifier.doi10.1111/dom.12919-
dc.identifier.scopuseid_2-s2.0-85018427664-
dc.identifier.hkuros271598-
dc.identifier.volume19-
dc.identifier.issue9-
dc.identifier.spage1312-
dc.identifier.epage1316-
dc.identifier.isiWOS:000408241200014-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats